Bovine lactoferrin suppresses the cathepsin-dependent pathway of SARS-CoV-2 entry in vitro

Kobayashi-Sakamoto et al., International Dairy Journal, doi:10.1016/j.idairyj.2023.105805, Sep 2023
In vitro study showing variant dependent inhibition of SARS-CoV-2 with bovine lactoferrin (bLF). Authors found that bLF did not suppress entry of wild-type pseudoviruses into cells that express both ACE2 and TMPRSS2, but did suppress entry of Omicron pseudoviruses. bLF suppressed entry of wild-type pseudoviruses into ACE2-expressing cells but not into TMPRSS2-expressing cells.
18 preclinical studies support the efficacy of lactoferrin for COVID-19:
Kobayashi-Sakamoto et al., 21 Sep 2023, peer-reviewed, 7 authors.
In vitro studies are an important part of preclinical research, however results may be very different in vivo.
DOI record: { "DOI": "10.1016/j.idairyj.2023.105805", "ISSN": [ "0958-6946" ], "URL": "http://dx.doi.org/10.1016/j.idairyj.2023.105805", "alternative-id": [ "S0958694623002248" ], "article-number": "105805", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Bovine lactoferrin suppresses the cathepsin-dependent pathway of SARS-CoV-2 entry in vitro" }, { "label": "Journal Title", "name": "journaltitle", "value": "International Dairy Journal" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.idairyj.2023.105805" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2023 Elsevier Ltd. All rights reserved." } ], "author": [ { "ORCID": "http://orcid.org/0000-0001-7472-2565", "affiliation": [], "authenticated-orcid": false, "family": "Kobayashi-Sakamoto", "given": "Michiyo", "sequence": "first" }, { "affiliation": [], "family": "Toyonobu", "given": "Maeda", "sequence": "additional" }, { "affiliation": [], "family": "Yusa", "given": "Junko", "sequence": "additional" }, { "affiliation": [], "family": "Shimada", "given": "Takahisa", "sequence": "additional" }, { "affiliation": [], "family": "Tani", "given": "Hideki", "sequence": "additional" }, { "affiliation": [], "family": "Kato", "given": "Yasumasa", "sequence": "additional" }, { "affiliation": [], "family": "Hirose", "given": "Kimiharu", "sequence": "additional" } ], "container-title": "International Dairy Journal", "container-title-short": "International Dairy Journal", "content-domain": { "crossmark-restriction": true, "domain": [ "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2023, 9, 21 ] ], "date-time": "2023-09-21T23:45:27Z", "timestamp": 1695339927000 }, "deposited": { "date-parts": [ [ 2023, 9, 21 ] ], "date-time": "2023-09-21T23:45:49Z", "timestamp": 1695339949000 }, "indexed": { "date-parts": [ [ 2023, 9, 22 ] ], "date-time": "2023-09-22T05:20:28Z", "timestamp": 1695360028018 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2023, 9 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 9, 1 ] ], "date-time": "2023-09-01T00:00:00Z", "timestamp": 1693526400000 } }, { "URL": "https://doi.org/10.15223/policy-017", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 9, 1 ] ], "date-time": "2023-09-01T00:00:00Z", "timestamp": 1693526400000 } }, { "URL": "https://doi.org/10.15223/policy-037", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 9, 1 ] ], "date-time": "2023-09-01T00:00:00Z", "timestamp": 1693526400000 } }, { "URL": "https://doi.org/10.15223/policy-012", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 9, 1 ] ], "date-time": "2023-09-01T00:00:00Z", "timestamp": 1693526400000 } }, { "URL": "https://doi.org/10.15223/policy-029", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 9, 1 ] ], "date-time": "2023-09-01T00:00:00Z", "timestamp": 1693526400000 } }, { "URL": "https://doi.org/10.15223/policy-004", "content-version": "stm-asf", "delay-in-days": 0, "start": { "date-parts": [ [ 2023, 9, 1 ] ], "date-time": "2023-09-01T00:00:00Z", "timestamp": 1693526400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0958694623002248?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0958694623002248?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "105805", "prefix": "10.1016", "published": { "date-parts": [ [ 2023, 9 ] ] }, "published-print": { "date-parts": [ [ 2023, 9 ] ] }, "publisher": "Elsevier BV", "reference": [ { "DOI": "10.3390/medicina57080842", "article-title": "The prospect of lactoferrin use as adjunctive agent in management of SARS-CoV-2 patients: A randomized pilot study", "author": "Algahtani", "doi-asserted-by": "crossref", "journal-title": "Medicina", "key": "10.1016/j.idairyj.2023.105805_bib1", "volume": "57", "year": "2021" }, { "DOI": "10.15252/embj.2020106765", "article-title": "Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans", "author": "Bermejo-Jambrina", "doi-asserted-by": "crossref", "journal-title": "EMBO Journal", "key": "10.1016/j.idairyj.2023.105805_bib2", "volume": "40", "year": "2021" }, { "DOI": "10.3390/ijerph182010985", "article-title": "Lactoferrin as antiviral treatment in COVID-19 management: preliminary evidence", "author": "Campione", "doi-asserted-by": "crossref", "journal-title": "International Journal of Environmental Research and Public Health", "key": "10.1016/j.idairyj.2023.105805_bib3", "volume": "18", "year": "2021" }, { "DOI": "10.3390/nu14245274", "article-title": "Can lactoferrin, a natural mammalian milk protein, assist in the battle against COVID-19?", "author": "Einerhand", "doi-asserted-by": "crossref", "journal-title": "Nutrients", "key": "10.1016/j.idairyj.2023.105805_bib4", "volume": "14", "year": "2022" }, { "DOI": "10.1099/vir.0.80955-0", "article-title": "Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein", "author": "Fukushi", "doi-asserted-by": "crossref", "first-page": "2269", "journal-title": "Journal of General Virology", "key": "10.1016/j.idairyj.2023.105805_bib5", "volume": "86", "year": "2005" }, { "DOI": "10.3389/fviro.2022.849936", "article-title": "Alpha, beta, delta, omicron, and SARS-CoV-2 breakthrough cases: Defining immunological mechanisms for vaccine waning and vaccine-variant mismatch", "author": "Hewins", "doi-asserted-by": "crossref", "journal-title": "Frontiers in Virology", "key": "10.1016/j.idairyj.2023.105805_bib6", "volume": "2", "year": "2022" }, { "DOI": "10.1016/j.cell.2020.02.052", "article-title": "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", "author": "Hoffmann", "doi-asserted-by": "crossref", "first-page": "271", "journal-title": "Cell", "key": "10.1016/j.idairyj.2023.105805_bib7", "volume": "181", "year": "2020" }, { "DOI": "10.1080/22221751.2021.1888660", "article-title": "The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "317", "journal-title": "Emerging Microbes & Infections", "key": "10.1016/j.idairyj.2023.105805_bib8", "volume": "10", "year": "2021" }, { "DOI": "10.1038/s41423-021-00836-z", "article-title": "Increased immune escape of the new SARS-CoV-2 variant of concern Omicron", "author": "Hu", "doi-asserted-by": "crossref", "first-page": "293", "journal-title": "Cellular & Molecular Immunology", "key": "10.1016/j.idairyj.2023.105805_bib9", "volume": "19", "year": "2022" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", "author": "Huang", "doi-asserted-by": "crossref", "first-page": "497", "journal-title": "Lancet", "key": "10.1016/j.idairyj.2023.105805_bib10", "volume": "395", "year": "2020" }, { "DOI": "10.1038/s41586-022-04479-6", "article-title": "SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo", "author": "Hui", "doi-asserted-by": "crossref", "first-page": "715", "journal-title": "Nature", "key": "10.1016/j.idairyj.2023.105805_bib11", "volume": "603", "year": "2022" }, { "DOI": "10.1016/bs.aivir.2016.08.004", "article-title": "Coronavirus spike protein and tropism changes", "author": "Hulswit", "doi-asserted-by": "crossref", "first-page": "29", "journal-title": "Advances in Virus Research", "key": "10.1016/j.idairyj.2023.105805_bib12", "volume": "96", "year": "2016" }, { "DOI": "10.1016/S0168-1702(99)00121-5", "article-title": "Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells", "author": "Ikeda", "doi-asserted-by": "crossref", "first-page": "51", "journal-title": "Virus Research", "key": "10.1016/j.idairyj.2023.105805_bib13", "volume": "66", "year": "2000" }, { "DOI": "10.1016/j.vaccine.2023.02.068", "article-title": "Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort", "author": "Itamochi", "doi-asserted-by": "crossref", "first-page": "2234", "journal-title": "Vaccine", "key": "10.1016/j.idairyj.2023.105805_bib14", "volume": "41", "year": "2023" }, { "DOI": "10.4062/biomolther.2020.201", "article-title": "Discovery of new fusion inhibitor peptides against SARS-CoV-2 by targeting the spike S2 subunit", "author": "Kandeel", "doi-asserted-by": "crossref", "first-page": "282", "journal-title": "Biomolecular Therapy", "key": "10.1016/j.idairyj.2023.105805_bib15", "volume": "29", "year": "2021" }, { "DOI": "10.1128/JVI.01933-08", "article-title": "Protease-mediated entry via the endosome of human coronavirus 229E", "author": "Kawase", "doi-asserted-by": "crossref", "first-page": "712", "journal-title": "Journal of Virology", "key": "10.1016/j.idairyj.2023.105805_bib16", "volume": "83", "year": "2009" }, { "DOI": "10.1002/jmv.27282", "article-title": "SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19", "author": "Kawasuji", "doi-asserted-by": "crossref", "first-page": "147", "journal-title": "Journal of Medical Virology", "key": "10.1016/j.idairyj.2023.105805_bib17", "volume": "94", "year": "2022" }, { "article-title": "The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria", "author": "Kell", "journal-title": "Frontiers in Immunology", "key": "10.1016/j.idairyj.2023.105805_bib18", "volume": "1221", "year": "2020" }, { "DOI": "10.1007/s00430-022-00760-7", "article-title": "Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity", "author": "Khatri", "doi-asserted-by": "crossref", "first-page": "103", "journal-title": "Medical Microbiology and Immunology", "key": "10.1016/j.idairyj.2023.105805_bib19", "volume": "212", "year": "2023" }, { "DOI": "10.1139/bcb-2021-0342", "article-title": "Bovine lactoferrin increases the poly(I:C)-induced antiviral response in vitro", "author": "Kobayashi-Sakamoto", "doi-asserted-by": "crossref", "first-page": "338", "journal-title": "Biochemistry and Cell Biology", "key": "10.1016/j.idairyj.2023.105805_bib20", "volume": "100", "year": "2022" }, { "DOI": "10.20965/jdr.2023.p0027", "article-title": "Lactoferrin as a possible preventive and therapeutic agent against SARS-CoV-2 infection", "author": "Kobayashi-Sakamoto", "doi-asserted-by": "crossref", "first-page": "27", "journal-title": "Journal of Disaster Research", "key": "10.1016/j.idairyj.2023.105805_bib21", "volume": "18", "year": "2023" }, { "DOI": "10.15252/embj.2021107821", "article-title": "TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells", "author": "Koch", "doi-asserted-by": "crossref", "journal-title": "EMBO Journal", "key": "10.1016/j.idairyj.2023.105805_bib22", "volume": "40", "year": "2021" }, { "DOI": "10.1371/journal.pone.0023710", "article-title": "Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans", "author": "Lang", "doi-asserted-by": "crossref", "journal-title": "PloS One", "key": "10.1016/j.idairyj.2023.105805_bib23", "volume": "6", "year": "2011" }, { "DOI": "10.1371/journal.ppat.1009500", "article-title": "The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways", "author": "Laporte", "doi-asserted-by": "crossref", "journal-title": "PLoS Pathogens", "key": "10.1016/j.idairyj.2023.105805_bib24", "volume": "17", "year": "2021" }, { "DOI": "10.1073/pnas.2300376120", "doi-asserted-by": "crossref", "key": "10.1016/j.idairyj.2023.105805_bib25", "unstructured": "Li, C., Huang, J., Yu, Y., Wan, Z., Chiu, M. C., Liu, X., et al. (2023). Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants. Proceedings of the National Academy of Sciences, USA, 120, Article e2300376120." }, { "DOI": "10.3390/nu15051285", "article-title": "Effect of lactoferrin on clinical outcomes of hospitalized patients with COVID-19: The LAC randomized clinical trial", "author": "Matino", "doi-asserted-by": "crossref", "journal-title": "Nutrients", "key": "10.1016/j.idairyj.2023.105805_bib26", "volume": "15", "year": "2023" }, { "DOI": "10.1038/s41586-022-04474-x", "article-title": "Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity", "author": "Meng", "doi-asserted-by": "crossref", "first-page": "706", "journal-title": "Nature", "key": "10.1016/j.idairyj.2023.105805_bib27", "volume": "603", "year": "2022" }, { "DOI": "10.1101/2020.05.27.117184", "doi-asserted-by": "crossref", "key": "10.1016/j.idairyj.2023.105805_bib28", "unstructured": "Mirabelli, C., Wotring, J. W., Zhang, C. J., McCarty, S. M., Fursmidt, R., Pretto, C. D., et al. (2021). Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proceedings of the National Academy of Sciences, USA, 118, Article e2105815118." }, { "DOI": "10.1007/s10534-022-00477-3", "article-title": "Bovine lactoferrin for the prevention of COVID-19 infection in health care personnel: a double-blinded randomized clinical trial (LF-COVID)", "author": "Navarro", "doi-asserted-by": "crossref", "first-page": "463", "journal-title": "Biometals", "key": "10.1016/j.idairyj.2023.105805_bib29", "volume": "36", "year": "2023" }, { "DOI": "10.1016/S0006-291X(03)00917-3", "article-title": "New functions of lactoferrin and β-casein in mammalian milk as cysteine protease inhibitors", "author": "Ohashi", "doi-asserted-by": "crossref", "first-page": "98", "journal-title": "Biochemical and Biophysical Research Communications", "key": "10.1016/j.idairyj.2023.105805_bib30", "volume": "306", "year": "2003" }, { "DOI": "10.1080/19420862.2022.2072455", "article-title": "Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants", "author": "Ozawa", "doi-asserted-by": "crossref", "journal-title": "mAbs", "key": "10.1016/j.idairyj.2023.105805_bib31", "volume": "14", "year": "2022" }, { "DOI": "10.1016/j.jtbi.2023.111568", "article-title": "Modelling how increased cathepsin B/L and decreased TMPRSS2 usage for cell entry by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and cathepsin B/L inhibitors", "author": "Padmanabhan", "doi-asserted-by": "crossref", "journal-title": "Journal of Theoretical Biology", "key": "10.1016/j.idairyj.2023.105805_bib32", "volume": "572", "year": "2023" }, { "DOI": "10.1016/j.idairyj.2022.105488", "article-title": "Hydrolysis improves the inhibition efficacy of bovine lactoferrin against infection by SARS-CoV-2 pseudovirus", "author": "Patil", "doi-asserted-by": "crossref", "journal-title": "International Dairy Journal", "key": "10.1016/j.idairyj.2023.105805_bib33", "volume": "137", "year": "2023" }, { "DOI": "10.1038/d41586-020-02379-1", "article-title": "COVID-19 poses a riddle for the immune system", "author": "Perlman", "doi-asserted-by": "crossref", "first-page": "345", "journal-title": "Nature", "key": "10.1016/j.idairyj.2023.105805_bib34", "volume": "584", "year": "2020" }, { "DOI": "10.1371/journal.ppat.1009013", "article-title": "The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors", "author": "Pišlar", "doi-asserted-by": "crossref", "journal-title": "PLoS Pathogens", "key": "10.1016/j.idairyj.2023.105805_bib35", "volume": "16", "year": "2020" }, { "DOI": "10.15252/embj.2021108944", "article-title": "SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced spike-mediated syncytia formation", "author": "Rajah", "doi-asserted-by": "crossref", "journal-title": "EMBO Journal", "key": "10.1016/j.idairyj.2023.105805_bib36", "volume": "40", "year": "2021" }, { "DOI": "10.1016/j.crvi.2014.08.003", "article-title": "Potential lactoferrin activity against pathogenic viruses", "author": "Redwan", "doi-asserted-by": "crossref", "first-page": "581", "journal-title": "Comptes Rendus Biologies", "key": "10.1016/j.idairyj.2023.105805_bib37", "volume": "337", "year": "2014" }, { "DOI": "10.3390/jcm10184276", "article-title": "Ambulatory COVID-19 patients treated with lactoferrin as a supplementary antiviral agent: a preliminary study", "author": "Rosa", "doi-asserted-by": "crossref", "journal-title": "Journal of Clinical Medicine", "key": "10.1016/j.idairyj.2023.105805_bib38", "volume": "10", "year": "2021" }, { "DOI": "10.3390/nu13020328", "article-title": "Protective effects of lactoferrin against SARS-CoV-2 infection in vitro", "author": "Salaris", "doi-asserted-by": "crossref", "journal-title": "Nutrients", "key": "10.1016/j.idairyj.2023.105805_bib39", "volume": "13", "year": "2021" }, { "DOI": "10.1016/j.csbj.2021.05.002", "article-title": "Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain", "author": "Schuurs", "doi-asserted-by": "crossref", "first-page": "2806", "journal-title": "Computational and Structural Biotechnology Journal", "key": "10.1016/j.idairyj.2023.105805_bib40", "volume": "19", "year": "2021" }, { "DOI": "10.1038/d41586-021-02039-y", "article-title": "How the coronavirus infects cells-and why Delta is so dangerous", "author": "Scudellari", "doi-asserted-by": "crossref", "first-page": "640", "journal-title": "Nature", "key": "10.1016/j.idairyj.2023.105805_bib41", "volume": "595", "year": "2021" }, { "DOI": "10.1002/rmv.2381", "article-title": "Evolution of the SARS‐CoV‐2 omicron variants BA. 1 to BA. 5: implications for immune escape and transmission", "author": "Shrestha", "doi-asserted-by": "crossref", "journal-title": "Reviews in Medical Virology", "key": "10.1016/j.idairyj.2023.105805_bib42", "volume": "32", "year": "2022" }, { "article-title": "Characterization of SARS-CoV-2 variants N501Y.V1 and N501Y.V2 spike on viral infectivity", "author": "Tang", "journal-title": "Frontiers in Cell Infection and Microbiology", "key": "10.1016/j.idairyj.2023.105805_bib43", "volume": "11", "year": "2021" }, { "DOI": "10.1186/s12985-021-01490-7", "article-title": "Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein", "author": "Tani", "doi-asserted-by": "crossref", "journal-title": "Virology Journal", "key": "10.1016/j.idairyj.2023.105805_bib44", "volume": "18", "year": "2021" }, { "DOI": "10.1016/j.jiac.2014.08.003", "article-title": "Lactoferrin for prevention of common viral infections", "author": "Wakabayashi", "doi-asserted-by": "crossref", "first-page": "666", "journal-title": "Journal of Infection Chemotherapy", "key": "10.1016/j.idairyj.2023.105805_bib45", "volume": "20", "year": "2014" }, { "article-title": "A novel hamster model of SARS-CoV-2 respiratory infection using a pseudotyped virus", "author": "Yamada", "journal-title": "Science Reports", "key": "10.1016/j.idairyj.2023.105805_bib46", "volume": "12", "year": "2022" }, { "DOI": "10.1038/s41598-023-35915-w", "article-title": "Evaluation of SARS-CoV-2 isolation in cell culture from nasal/nasopharyngeal swabs or saliva specimens of patients with COVID-19", "author": "Yazawa", "doi-asserted-by": "crossref", "journal-title": "Scientific Reports", "key": "10.1016/j.idairyj.2023.105805_bib47", "volume": "13", "year": "2023" }, { "DOI": "10.1016/j.cell.2020.09.032", "article-title": "Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant", "author": "Yurkovetskiy", "doi-asserted-by": "crossref", "first-page": "739", "journal-title": "Cell", "key": "10.1016/j.idairyj.2023.105805_bib48", "volume": "183", "year": "2020" }, { "DOI": "10.1016/j.intimp.2021.107571", "article-title": "The potential for lactoferrin to reduce SARS-CoV-2 induced cytokine storm", "author": "Zimecki", "doi-asserted-by": "crossref", "journal-title": "International Immunopharmacology", "key": "10.1016/j.idairyj.2023.105805_bib49", "volume": "95", "year": "2021" } ], "reference-count": 49, "references-count": 49, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0958694623002248" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Applied Microbiology and Biotechnology", "Food Science" ], "subtitle": [], "title": "Bovine lactoferrin suppresses the cathepsin-dependent pathway of SARS-CoV-2 entry in vitro", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy" }